Figure 2 | Scientific Reports

Figure 2

From: M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer

Figure 2

“M1” high tumors did not demonstrate the association with response to neoadjuvant chemotherapy. The association between expression of “M1” and pCR rate. GSE20194 (ER+/HER2−, n = 129, High = 60, Low = 69; TNBC, n = 68, High = 34, Low = 34). GSE22358 (ER+/HER2−, n = 67, High = 34, Low = 33; TNBC, n = 50, High = 25, Low = 25). GSE25066 (ER+/HER2−, n = 289, High = 145, Low = 144; TNBC, n = 178, High = 90, Low = 88). GSE32646 (ER+/HER2−, n = 55, High = 28, Low = 27; TNBC, n = 26, High = 13, Low = 13). TNBC, triple negative breast cancer.

Back to article page